LabGenomics Co. Ltd (084650) — Financial Flexibility Index
LabGenomics Co. Ltd (084650) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of ₩-5.93 Billion (operating CF ₩-6.41 Billion minus capex ₩480.02 Million) represents 0% of total liabilities (₩76.00 Billion). Also explore 084650 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LabGenomics Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for LabGenomics Co. Ltd across 11 annual periods. Check asset allocation strategy of LabGenomics Co. Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for LabGenomics Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for LabGenomics Co. Ltd. For the full company profile including market capitalisation, see 084650 market cap overview.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.11x | ₩-8.45 Billion | ₩-12.99 Billion | ₩79.35 Billion | ▼ -219.2% |
| 2023 | 0.09x | ₩7.62 Billion | ₩2.42 Billion | ₩85.31 Billion | ▼ -96.6% |
| 2022 | 2.62x | ₩108.20 Billion | ₩69.87 Billion | ₩41.32 Billion | ▲ +54.2% |
| 2021 | 1.70x | ₩79.08 Billion | ₩65.36 Billion | ₩46.57 Billion | ▲ +0.4% |
| 2020 | 1.69x | ₩47.07 Billion | ₩46.37 Billion | ₩27.82 Billion | ▲ +760.2% |
| 2019 | 0.20x | ₩3.75 Billion | ₩3.19 Billion | ₩19.06 Billion | ▲ +26.8% |
| 2018 | 0.16x | ₩2.64 Billion | ₩608.03 Million | ₩16.99 Billion | ▼ -16.3% |
| 2017 | 0.19x | ₩3.25 Billion | ₩-1.06 Billion | ₩17.52 Billion | ▼ -49.1% |
| 2016 | 0.36x | ₩6.62 Billion | ₩2.54 Billion | ₩18.17 Billion | ▼ -50.4% |
| 2015 | 0.73x | ₩7.00 Billion | ₩2.38 Billion | ₩9.54 Billion | ▲ +66.4% |
| 2014 | 0.44x | ₩4.35 Billion | ₩3.15 Billion | ₩9.86 Billion | — |